Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

MIS Sacroiliac Joint Fusion Market Size & Growth Forecast 2027–2036, By Segments (Approach, Product, End-use, Indication), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 21562| Published Date: Aug-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

MIS Sacroiliac Joint Fusion Market size was valued at USD 1.05 Billion in 2026 and is anticipated to grow at 12.58% CAGR from 2027 to 2036, surpassing USD 3.43 Billion by 2036. The industry revenue for 2027 is calculated at USD 1.16 Billion.

Base Year Value (2026)
USD 1.05 Billion
CAGR (2027-2036)
12.58%
Forecast Year Value (2036)
USD 3.43 Billion
Historical Data Period
2022-2026
Largest Region
North America
Forecast Period
2027-2036

Get more details on this report

Request Free Sample Report
SNAPSHOT

MIS Sacroiliac Joint Fusion Market Intelligence Snapshot

Regional Market Dynamics

  • North America led in 2026 due to advanced healthcare infrastructure, established minimally invasive procedure adoption, specialized facilities, and experienced clinicians.
  • Asia Pacific is expanding as healthcare infrastructure, specialist training, and access to advanced orthopedic procedures improve alongside demand for minimally invasive treatments.

Segment Momentum

  • Implants dominated with a 61.73% share in 2026 because they enable durable joint stabilization, improved fusion outcomes, and enhanced minimally invasive procedure effectiveness.
  • The anterior approach is the fastest-growing segment as improved imaging guidance and surgical techniques support individualized planning, better implant placement, and broader minimally invasive treatment adoption.

Market Expansion Drivers

  • Rising geriatric population increasing prevalence of sacroiliac joint dysfunction and chronic pain cases
  • Growing adoption of minimally invasive spinal procedures improving patient recovery and surgical outcomes
  • Technological advancements in implant systems enhancing precision and success rates in joint fusion procedures

Leading Market Participants

  • Major companies in the MIS sacroiliac joint fusion market include SI-BONE, Inc. (United States), Medtronic plc (Ireland), Globus Medical, Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), Orthofix Medical Inc. (United States), PainTEQ (United States), Life Spine, Inc. (United States), SIGNUS Medizintechnik GmbH (Germany), CoreLink Surgical (United States), Xtant Medical Holdings, Inc. (United States)

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

  • 2026 Market Size: USD 1.05 Billion
  • 2027 Estimated Market Size: USD 1.16 Billion
  • Projected Market Size: USD 3.43 Billion by 2036
  • Growth Forecast: 12.58% CAGR (2027-2036)

Regional and Segment Outlook

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Dorsal (Approach) | Implants (Product) | Hospitals (End-use) | Degenerative Sacroiliitis (Indication)
  • Emerging Opportunity Segment: Anterior (Approach) | Implants (Product) | Ambulatory Surgical Centers (End-use) | Sacroiliac Joint Dysfunction (Indication)
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising geriatric population increasing prevalence of sacroiliac joint dysfunction and chronic pain cases

The growing proportion of older adults worldwide is contributing to a higher incidence of degenerative musculoskeletal disorders, which will drive the MIS sacroiliac joint fusion market growth. Aging is closely associated with progressive wear of the sacroiliac joint, reduced joint stability, and chronic lower back pain, increasing the number of patients seeking effective long-term treatment options. As conservative therapies may provide limited relief for persistent sacroiliac joint dysfunction, healthcare providers are increasingly evaluating minimally invasive fusion procedures for appropriately selected patients. Greater awareness of age-related spinal conditions and improved diagnostic capabilities are also supporting earlier identification of sacroiliac joint disorders, leading to broader utilization of targeted surgical interventions in orthopedic and spine care settings.

Growing adoption of minimally invasive spinal procedures improving patient recovery and surgical outcomes

A strong preference for less invasive surgical techniques is creating favorable conditions for the MIS sacroiliac joint fusion market as clinicians prioritize procedures that minimize tissue disruption while enhancing patient recovery. Minimally invasive approaches are designed to reduce operative trauma, shorten hospital stays, and facilitate faster postoperative rehabilitation compared with conventional open surgeries. These advantages are particularly valuable for patients with chronic sacroiliac joint pain who seek effective treatment with reduced procedural burden. Healthcare systems are also supporting minimally invasive techniques because they can improve workflow efficiency, optimize resource utilization, and contribute to more predictable recovery pathways across spine surgery programs.

Technological advancements in implant systems enhancing precision and success rates in joint fusion procedures

Continuous innovation in implant design and surgical technologies is expected to propel the MIS sacroiliac joint fusion market growth by improving procedural accuracy and clinical performance. Modern implant systems are being developed with enhanced biomechanical stability, optimized anatomical compatibility, and instrumentation that supports precise placement during surgery. Advances in imaging guidance, navigation technologies, and specialized delivery instruments further assist surgeons in achieving accurate implant positioning while minimizing procedural complexity. These developments contribute to greater confidence in minimally invasive sacroiliac joint fusion by supporting consistent fixation and promoting effective bone fusion across a broad range of patient profiles.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising geriatric population increasing prevalence of sacroiliac joint dysfunction and chronic pain cases 3.6% High North America, Europe High Near Term
Growing adoption of minimally invasive spinal procedures improving patient recovery and surgical outcomes 3.8% High North America, Asia Pacific High Near Term
Technological advancements in implant systems enhancing precision and success rates in joint fusion procedures 3.7% High North America, Europe Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
Largest Market Share in 2026

North America (Largest Region)

North America held the largest share of the MIS sacroiliac joint fusion market in 2026, reflecting the region's advanced healthcare infrastructure and established adoption of minimally invasive surgical procedures. Growing awareness of less invasive treatment approaches, combined with the availability of specialized surgical facilities and experienced clinicians, is supporting demand for sacroiliac joint fusion procedures. The region's focus on improving surgical outcomes while reducing procedural trauma and recovery requirements is also encouraging the use of minimally invasive techniques.

Asia Pacific (Fastest-Growing Region)

The MIS sacroiliac joint fusion market is expected to expand rapidly across Asia Pacific as healthcare infrastructure improves and access to advanced orthopedic procedures increases. Rising awareness of minimally invasive treatment options is encouraging healthcare providers to broaden their surgical capabilities, while improvements in hospital facilities and specialist training are supporting greater procedural adoption. Increasing demand for effective treatment of musculoskeletal disorders, together with healthcare modernization and expanding access to specialized care, is creating a favorable environment for market growth in the region.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

United States 🇺🇸

Outpatient Procedure Focus

The U.S. emphasizes minimally invasive sacroiliac joint fusion procedures that reduce hospital stays and support ambulatory care. Healthcare providers in the U.S. continue evaluating implants with improved surgical precision and clinical evidence for chronic pain management.

Germany 🇩🇪

Evidence-Based Adoption

Germany prioritizes clinically validated MIS sacroiliac joint fusion systems supported by long-term outcomes and surgeon training. Hospitals in Germany increasingly integrate advanced navigation and implant technologies to improve procedural consistency.

Japan 🇯🇵

Precision Surgical Integration

Japan focuses on minimally invasive sacroiliac joint fusion solutions compatible with precision surgical workflows and aging patient care. Healthcare providers in Japan value implant reliability and techniques that minimize recovery time and procedural complexity.

South Korea 🇰🇷

Technology-Enabled Orthopedics

South Korea promotes advanced orthopedic procedures supported by imaging, navigation, and minimally invasive surgical platforms. Hospitals in South Korea are adopting sacroiliac joint fusion technologies that enhance procedural efficiency and patient recovery.

France 🇫🇷

Clinical Practice Standardization

France prioritizes standardized surgical protocols and clinically supported MIS sacroiliac joint fusion techniques. Healthcare institutions in France evaluate implant systems that align with quality-of-care objectives and consistent patient outcomes.

Italy 🇮🇹

Specialist Spine Expansion

Italy continues strengthening specialist spine centers performing minimally invasive sacroiliac joint fusion procedures. Surgeons in Italy increasingly favor implant systems that simplify workflows while supporting durable fixation and postoperative recovery.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Go beyond the chart, access full insights & data tables

Request Free Sample Report

Approach Segment Analysis: Dorsal (Largest Segment) vs Anterior (Fastest-Growing Segment)

The MIS sacroiliac joint fusion market was led by the dorsal approach segment, which accounted for 61.37% of the market share in 2026. The dorsal approach is widely preferred because it provides effective stabilization while minimizing disruption to surrounding anatomical structures. Its established clinical use, familiarity among spine surgeons, and compatibility with minimally invasive surgical techniques have contributed to consistent adoption, supporting improved patient recovery and procedural efficiency.

The anterior approach segment is anticipated to witness the fastest growth as advancements in surgical techniques and imaging guidance expand the range of minimally invasive treatment options available to clinicians. Growing emphasis on individualized surgical planning, improved implant placement, and enhanced patient outcomes is encouraging broader adoption of anterior procedures for appropriately selected cases.

Product Segment Analysis: Implants (Largest & Fastest-Growing Segment)

The implants segment dominated the MIS sacroiliac joint fusion market with a 61.73% share in 2026 while also representing the fastest-growing product category. Implants are fundamental to achieving durable sacroiliac joint stabilization and promoting long-term fusion outcomes. Continuous innovation in implant materials, design optimization, and minimally invasive delivery systems has improved procedural effectiveness, encouraging greater adoption among healthcare providers and supporting the segment's continued market leadership.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Holding the largest share of the MIS sacroiliac joint fusion market, the hospitals segment captured 57.24% in 2026. Hospitals remain the primary setting for minimally invasive spine procedures because they provide comprehensive surgical infrastructure, multidisciplinary clinical expertise, and advanced postoperative care. Their ability to manage complex cases and support specialized orthopedic and neurosurgical services continues to reinforce their leading position in the market.

The ambulatory surgical centers segment is expected to register the fastest growth as healthcare systems increasingly emphasize cost-effective, minimally invasive procedures performed in outpatient settings. Advances in surgical techniques, shorter recovery times, and growing patient preference for same-day treatment are encouraging more sacroiliac joint fusion procedures to be performed in ambulatory surgical centers while maintaining high standards of clinical care.

Segment Sub-Segment Largest Segment Fastest Growing
Approach Dorsal, Anterior Dorsal Anterior
Product Implants, Instruments & Equipment Implants Implants
End-use Hospitals, Ambulatory Surgical Centers, Others Hospitals Ambulatory Surgical Centers
Indication Trauma, Degenerative Sacroiliitis, Sacroiliac Joint Dysfunction Degenerative Sacroiliitis Sacroiliac Joint Dysfunction
Competitive Landscape

Competitive Landscape and Market Positioning

Major players in the MIS sacroiliac joint fusion market:

  1. SI-BONE, Inc. (United States)
  2. Medtronic plc (Ireland)
  3. Globus Medical, Inc. (United States)
  4. Zimmer Biomet Holdings, Inc. (United States)
  5. Orthofix Medical, Inc. (United States)
  6. PainTEQ (United States)
  7. Life Spine, Inc. (United States)
  8. SIGNUS Medizintechnik GmbH (Germany)
  9. CoreLink Surgical (United States)
  10. Xtant Medical Holdings, Inc. (United States)

Competition within the MIS sacroiliac joint fusion market is evolving around procedural consistency, implant design refinement, and the ability to improve minimally invasive surgical outcomes. Device developers are focusing on solutions that support surgeon adoption through easier handling, improved procedural workflows, and compatibility with evolving surgical techniques. As clinical expectations continue to rise, market positioning increasingly depends on demonstrating meaningful advantages in procedural efficiency and patient care while maintaining strong evidence and regulatory support.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
SI-BONE Inc. (United States)
Medtronic plc (Ireland)
Globus Medical Inc. (United States)
Zimmer Biomet Holdings Inc. (United States)
Orthofix Medical Inc. (United States)
PainTEQ (United States)
Life Spine Inc. (United States)
SIGNUS Medizintechnik GmbH (Germany)
CoreLink Surgical (United States)
Xtant Medical Holdings Inc. (United States)
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
CoreLink Mar-23 CoreLink received FDA clearance for its Siber Ti 3D-printed SI joint fusion system, featuring patented Mimetic Metal technology with macro, micro, and nano-level architecture designed to emulate natural bone structure and enhance clinical adoption.
CornerLoc Oct-22 CornerLoc unveiled the TransLoc 3D SI joint fusion system, introducing a hybrid construct that combines modular posterior implants and lateral oblique screws to advance sacroiliac joint fixation techniques and procedural versatility.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

MIS Sacroiliac Joint Fusion Market — Custom Segments

Segment Sub-Segment
Patient Age Group Young Adults, Middle-aged Adults, Older Adults
Surgeon Specialty Orthopedic Surgeons, Neurosurgeons, Spine Surgeons
Care Pathway Conservative Treatment Failure, Post-traumatic Management, Chronic Pain Management, Revision Surgery

MIS Sacroiliac Joint Fusion Market — report.custom

Custom Chapter Custom Details
Patient Selection & Procedure Adoption
  • Patient selection criteria shaping procedure adoption
  • Clinical decision drivers and procedure positioning
  • Adoption patterns across physician and care settings
  • Barriers to broader procedural utilization
  • Expansion opportunities in eligible patient populations
Reimbursement & Health Economics
  • Reimbursement environment and coverage considerations
  • Economic value drivers across care pathways
  • Procedure cost and resource-utilization considerations
  • Health-economic evidence and adoption implications
Hospital Procurement Dynamics
  • Hospital purchasing priorities and decision criteria
  • Capital and clinical procurement considerations
  • Stakeholder requirements across procurement processes
  • Vendor evaluation and contracting priorities
  • Procurement implications for procedure adoption

Need a different cut of the data?

Request Custom Research
report.faq_name

How large is the MIS sacroiliac joint fusion market?

In 2027 the market for MIS sacroiliac joint fusion is valued at USD 1.16 Billion.

What is the expected industry size of MIS sacroiliac joint fusion by 2036?

MIS Sacroiliac Joint Fusion Market size was valued at USD 1.05 Billion in 2026 and is anticipated to grow at 12.58% CAGR from 2027 to 2036, surpassing USD 3.43 Billion by 2036.

Which clinical trends are accelerating adoption of minimally invasive sacroiliac joint fusion procedures?

Growing demand for effective chronic pain management and less invasive surgical approaches is encouraging healthcare providers to adopt procedures that reduce recovery burden, improve outcomes, and optimize surgical efficiency.

How are technological advancements influencing MIS sacroiliac joint fusion procedures?

Innovations in implant systems, imaging guidance, and surgical instruments are improving procedural precision, supporting accurate implant placement, and enhancing confidence in minimally invasive fusion techniques.

Why are implants the leading product segment in the MIS sacroiliac joint fusion market?

Implants dominated with a 61.73% share in 2026 because they enable durable joint stabilization, improved fusion outcomes, and enhanced minimally invasive procedure effectiveness.

How is the anterior approach segment expanding in MIS sacroiliac joint fusion?

The anterior approach is the fastest-growing segment as improved imaging guidance and surgical techniques support individualized planning, better implant placement, and broader minimally invasive treatment adoption.

Why does North America lead the MIS sacroiliac joint fusion market?

North America led in 2026 due to advanced healthcare infrastructure, established minimally invasive procedure adoption, specialized facilities, and experienced clinicians.

What is driving MIS sacroiliac joint fusion growth in Asia Pacific?

Asia Pacific is expanding as healthcare infrastructure, specialist training, and access to advanced orthopedic procedures improve alongside demand for minimally invasive treatments.

Who holds a significant market share in the MIS sacroiliac joint fusion landscape?

Major companies in the MIS sacroiliac joint fusion market include SI-BONE, Inc. (United States), Medtronic plc (Ireland), Globus Medical, Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), Orthofix Medical Inc. (United States), PainTEQ (United States), Life Spine, Inc. (United States), SIGNUS Medizintechnik GmbH (Germany), CoreLink Surgical (United States), Xtant Medical Holdings, Inc. (United States)
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →